Showing results (391-400 of 398) with videos related to
Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 398 results.
Scandinavian Journal of Rheumatology|April 14, 2021
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patientsAys Lee, K A Patterson, D J Tan, et al.Journal of Medicinal Chemistry|February 28, 1997
4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activityR W Carling, P D Leeson, K W Moore, et al.Rheumatology (Oxford, England)|January 2, 2003
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controlsD R Haynes, E Barg, T N Crotti, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components AnalysisK A Patterson, P J Roberts-Thomson, S Lester, et al.Annales Chirurgiae Et Gynaecologiae|May 23, 1998
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working GroupN O'Higgins, D A Linos, M Blichert-Toft, et al.Journal of Medicinal Chemistry|December 24, 1997
Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonistsM Rowley, J J Kulagowski, A P Watt, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trialJ M Weiss, T Csoszi, M Maglakelidze, et al.Nature|March 10, 2006
A photometric redshift of z = 6.39 +/- 0.12 for GRB 050904J B Haislip, M C Nysewander, D E Reichart, et al.Pageof 40